All articles by GlobalData Healthcare

  1. DBV and Aimmune poised to dominate peanut allergy market

    Last week, the top two contenders for first peanut allergy immunotherapy to market—DBV Technologies and Aimmune Therapeutics—presented to investors at…
    Read More…

    19 Jan
  2. Comorbidities are a significant concern in people with Type 2 diabetes

    Figure 1: 7MM, Diagnosed Prevalent Cases of Type 2 Diabetes with Comorbidity, 2016, Men and Women, Ages ≥20 Years. Source:…
    Read More…

    16 Jan
  3. Through CRISPR gene editing we can change the nature of our species

    In 2018, we can expect to see large numbers of CRISPR trials taking off all over the world and we…
    Read More…

    12 Jan
  4. Vertex prepares to bolster pipeline portfolio

    Pavan Kottamasu, GlobalData Healthcare & Pharmaceutical Analyst, Jeffrey Leiden, M.D., Ph.D., Chairman, President, and CEO of Vertex Pharmaceuticals, took the…
    Read More…

    12 Jan
  5. Amgen/UCB’s bone-forming agent, Evenity, accepted for review by EMA

    On January 8, the European Medicine Agency (EMA) accepted Amgen and UCB’s submission for review for use of Evenity (romosozumab),…
    Read More…

    12 Jan
  6. Can Liquidia’s LIQ861 offer a more convenient and effective treprostinil option for PAH patients?

    On January 3, 2018, Liquidia Technologies announced the initiation of a Phase III clinical trial evaluating LIQ861 (inhaled treprostinil) for…
    Read More…

    11 Jan
  7. Four Developers that Will Expand the Use of FLT3 Inhibitors in the AML Market

    Each bubble represents a different industrial sponsor. Bubble size represents the number of Phase I–III clinical trials for that sponsor….
    Read More…

    4 Jan
  8. Revived leukemia drug follows a historical development path in three stages

    Over the course of 2017, the acute myeloid leukemia (AML) market has experienced dramatic changes with the approval of various…
    Read More…

    4 Jan
  9. Diabetic macular edema: eye screenings will be critical in preventing vision loss

    Diabetes is one of the fastest growing non-communicable diseases in the US. According to a 2017 report published by the…
    Read More…

    3 Jan
  10. Phase I trials on the rise in New Zealand

    GlobalData has compiled a summary of clinical trials in New Zealand. GlobalData captured records of 1,016 clinical trials across all…
    Read More…

    3 Jan